China's Ascentage Pharma targets $1.8b valuation in US IPO

China's Ascentage Pharma targets $1.8b valuation in US IPO

Photo by Madison Agardi on Unsplash.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter